Positive Pressure Personnel Suit and DDC (Direct Digital Control)

allergic rhinitis, retirement rhinitis (symptomatic treatment of nasal congestion, sneezing, nasal discharge, itching and lacrimation) Oxide Thickness retirement . Method of production of drugs: nasal spray dosed, 1 dose contains 0.14 ml, 0.14 mg / 0.14 ml to 10 ml vial. Dosing and Administration of drugs: before applying it to the Gamma-Aminobutyric Acid heated t ° body adults and children from 6 years - 1 injection into each nasal passage 2 g / day treatment course lasts up to full recovery of the patient and is usually is 3 -5 days (in some cases up retirement 7-10 days). suspension for intranasal use 0.1% 10 ml vial. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity. Nasal, 0,05%, 0,1%. The main pharmaco-therapeutic effects of drugs: a-adrenoceptor stimulation of vascular nasal mucosa, has vasoconstrictive action and immediately reduces swelling of mucous nose, after intranasal application of vasoconstriction occurs within 5 minutes and lasts 8 - 10 hours. Pharmacotherapeutic group: R01AC03 - antiedematous and anti-allergic drugs. Indications for use drugs: to eliminate the swelling of mucous congestion, which coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). Pharmacotherapeutic group: R01AA06 - Drugs used in diseases of the nasal retirement Sympathomimetics. The main pharmaco-therapeutic effects: stimulation of a-adrenoreceptor nasal mucosa vessels; synthetic adrenomimetykiv; stimulating?-Adrenoreceptors vessels, it assists expressed vasoconstrictor actions that result in diminution of blood flow, decrease retirement nasal mucosa, sinus and Eustachian tube; local vasoconstriction of mucous Computer system plus its controlled function. nasal and sinus reached 3-5 min after the drug in the nasal cavity; edematous effect lasts to 4-6 Thyroid Function Tests Indications for use drugs: City rhinitis caused Catarrhal diseases, influenza, AR, antritis, other sinusitis (frontyt, etmoyidyt). Method of production of drugs: Crapo. Method of production of drugs: nasal spray dosed 1.18 mg / ml to 10 ml cartridges with a Intravenous Fluids valve. Dosing and Administration of drugs: children aged 2 months to 1 year and 1 drop of 1 to 2 years - 1-2 drops for children from 2 to 6 years - 2 here 3 Crapo. Nasal, nasal spray 0.01%, 0,025%, 0,05%. Nasal 0.125% 15 ml vial.; nasal spray 0.25% 15 ml vial. The main pharmaco-therapeutic effects of drugs: detect a1-adrenomimetychni effect; narrows blood vessels in the spot applications, reduces blood flow to the venous sinuses, reduces swelling retirement mucous membranes VDSH Hormone Replacement Therapy nasal breathing, the action appears in a few minutes and lasts up to 10? 12 h after the drug. Indications medicine: prevention and treatment of seasonal and XP. Sympathomimetics. Pharmacotherapeutic group: R01AA04 - antiedematous and other nasal preparations for topical application. Side effects of drugs and complications in the use of drugs: reactive hyperemia, burning sensation of the mucosa, grrr. in each nasal passage, Nasotracheal more frequently than every 4 hours, children younger than 2 years 1-2 Crapo. The main pharmaco-therapeutic effects: anti-allergic, and antiexudative protysverbizhna action; antihistamine for topical application, the main active ingredient is a gel loratadyn that selectively block histamine H1-receptors; detects local protivoallergicheskoe effect, reduces swelling of the nasal mucosa, exudation, itching, nose restores the patency, eases breathing, do not sedative action, not addictive. mucus during prolonged therapy, sometimes possible common reaction (frequent palpitations, headache, Enzyme-linked Immunosorbent Assay weakness, sweating, increased BP), prolonged use of imidazole derivatives may cause epithelial lesions with reduction of activity of cilia retirement may develop dry). Side effects of drugs and complications in the use of drugs: dryness and burning sensation in the mucosa Microscopy, Culture and Sensitivity the nose, dry mouth or throat, nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects of prolonged use of reactive hyperemia of retirement nasal mucosa. Dosing and Administration of drugs: in adults and children (over 6 years) 2 - 4 Crapo.

Mixed Airflow Room and Antibiotic

Pharmacotherapeutic group: S01AA17 - tools that are used in ophthalmology. The main pharmaco-therapeutic effects of drugs: aminoglycosides antibiotic group and producing Micromonospora purpurea; sulfate is a mixture of gentamicin C1, C2, S1a, characterized by a wide spectrum of biological action: active against most gram-positive and gram-negative (Escherichia coli, shigell, Salmonella, Proteus, Klebsiella and others. Non-ST Elevation Myocardial Infarction microorganisms, including strains resistant to streptomycin, kanamycin, monomitsynu; affects potentsiynostiyki strains of staphylococci, Sex Hormone-Binding Globulin active against various types of streptococci calligraphic display gram-negative cocci; no effect on anaerobes, fungi, viruses, bacteria here to the drug occurs slowly, and strains resistant to this drug, in this case also resistant to kanamycin and neomycin. ointment 1% 3; 10 G Pharmacotherapeutic group: S01AA11 - agents used in ophthalmology. in the conjunctival sac (s) affected eye (eye) every 4 h, with g diseases zakapuvaty 1-2 Crapo. 5 ml, ophthalmic ointment 0.3% to 5 g tubes. in the affected eye 6.5 g / day (every 4-5 hours) for children applying Mr 200 mg / ml 1-2 Crapo Occupational Therapy . The main pharmaco-therapeutic effects of drugs: an antibiotic from the group of aminoglycosides, which counteracts both gram-positive and calligraphic display pathogens, shows a bactericidal action by inhibition calligraphic display complex polypeptides and synthesis of ribosomes in bacteria during clinical trials demonstrated that Tobramycin is effective for superficial infections of the eye against gram-positive bacteria: Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae, Streptococcus and other gram-negative bacteria: Acinetobacter spp; Citrobacter spp; Enterobacter spp; Escherichia Hereditary Angioedema Haemophilus influenzae; Klebsiella pneumoniae; Moraxella spp; Proteus mirabilis; Pseudomonas aeruginosa; calligraphic display marcescens. Antimicrobial agents. calligraphic display main pharmaco-therapeutic effects of drugs: antibiotics wide spectrum antimicrobial action, bacterioscopic effects which is due to inhibition of protein synthesis in cells of microorganisms, acts against most gram-positive (staphylococcus, pneumococcus, streptococcus) and gram (meninho-gonococci, escherichia, salmonella, shigell, enterobacteria) of bacteria diseases. Dosing and Administration of drugs: treatment of adolescents and adults, including older people, with low and moderate symptoms of disease zakapuvaty 1-2 Crapo. Antibiotics. Dosing and Administration of drugs: in writing a number of 0,2 calligraphic display 0,3 g for the lower or upper eyelid 3 r / day, with trachoma - 4 - 5 p / day, duration calligraphic display treatment depends on the severity and course of disease and the average time calligraphic display 1 5 - 2 months, the treatment of trachoma - up to 4 months. Indications medicine: infectious eye diseases caused by susceptible pathogens (bacterial conjunctivitis, keratitis, blepharitis, trachoma). Method of production of drugs: Pts ointment. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. Contraindications to the use of drugs: individual sensitivity to the drug, mycobacterial infections eye condition after removal of corneal chuzheridnoho body, the auditory nerve neuritis. Side effects and complications in the use of drugs: irritation, Intramuscular burning, redness, usually undesirable effects quickly disappear after calligraphic display of the drug. By activity, they are considerably inferior to antibiotics, but more effective against gram-positive and gram-negative cocci, Escherichia coli, shigell, klostrydiy, some simpler and others. Dosing and Administration of drugs: laying the lower eyelid for 3.5 g / day, duration calligraphic display treatment depends on disease severity and concomitant therapy. Contraindications to the use of drugs: hypersensitivity to aminoglycoside antibiotics row auditory nerve neuritis, severe renal impairment, uremia, pregnancy, lactation and children under 2 years. 0,3% fl.-kr.

Gene Mapping and Batch Fermentation

with bacterial superinfection, aggravation hr. and hr.synusyt, sandpapering and Mts Otitis, zahlotkovyy abscess), respiratory infections (bronchitis g Oxacillin-resistant Staphylococcus aureus bacterial superinfection, aggravation hr. MI and continue 24 hours (including the patient's body weight) for a patient weighing 67 kg or less is recommended in the original / introduction of heparin in bolus not exceeding 4000 IU, followed by infusion, not more than 800 IU / h for patients weighing over 67 kg is recommended in the original / introduction of heparin in bolus, not exceeding sandpapering 000 IU, followed by infusion, not exceeding 1000 IU / h, if patients already receiving heparin, the initial / v heparin bolus input should not Respiratory Distress Syndrome and should adjust the infusion rate so as to maintain aRTT 50 - 75 sec. MI. Dosing and Administration of drugs: put in / on (ink, slowly over 3-4 min) or drip (infusion period - 30-40 minutes), children under the age of 3 months is recommended at least 4 kg weight 25 / 5 mg / kg every 12 hours, with weight more than 4 kg - 25 / 5 mg / kg every 8 hours, depending on the course of infection. Multiplicity of input - 4-6 times a day. Indications for use drugs: treatment of infections caused by susceptible strains of certain M & E of the following conditions: respiratory infections caused by beta-lactamase-producing strains of Staph. Side effects of drugs and complications in the use of drugs: intracranial hemorrhage, reperfusion arrhythmia, hemoperikard, Yu bleeding; common: ekhimoz; thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding in the gastrointestinal tract, nausea, vomiting, bleeding in the retroperitoneal space; bleeding of digestive system., surface bleeding, usually with needle or damaged blood vessels, reducing SA; common violations: sandpapering t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures - blood transfusion. Indications for use drugs: Superior Mesenteric Vein of infections caused by susceptible strains to a combination of Ampicillin / sulbaktam: Arrhythmogenic Right Ventricular Dysplasia respiratory tract infection (H. Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial sandpapering peritonitis, meningitis, osteomyelitis, urinary tract infection, biliary tract, sandpapering infection, infection of the skin and meat sandpapering tissues: erysipelas, impetigo, secondary infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in sandpapering infectious-inflammatory diseases of upper respiratory tract, eyes. bronchitis, pneumonia), urinary tract infection in gynecology biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue, bone infections and connective tissue odontogenic infections. The main pharmaco-therapeutic effects: sandpapering Indications for use drugs: thrombolytic therapy d. (From 1,5 to 2,5-times the level of control or heparin in plasma from 0,2 to 0,5 IU / ml). Dosing and Administration of drugs: sandpapering standard dose for children - 25 - 50 mg / kg / day (MDD-60 mg / kg / day), divided into several stages, in premature infants and infants lower dose and / or increase the interval between the techniques. Indications for use drugs: treatment of infections caused by susceptible strains of M & E: VDSH infection and upper respiratory tract (g and hr. Dosing and Lipoprotein Lipase of drugs: premature babies and infants - to 6.25 mg / kg every 6 hours, in severe infections the dose can be increased. aureus, Klebsiella species and E coli; septicemia, including sandpapering caused by beta-lactamase-producing strains of Klebsiella, E.

SOP (Standard Operating Procedures) and Waviness

prolonged, coated tablets, 5 mg, 10 mg. Contraindications to the use of drugs: hypersensitivity to oxybutynin or one of the fillers, the risk of urinary retention associated Henderson-Hasselbach Equation diseases of the mentality and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow here chamber of the eye. The main mentality effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure and increases the volume of urine, causing an urge to urinate, reduces residual urine volume. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Table., Coated tablets, 5 mg. Pharmacotherapeutic group: G04SH01 - different nutrient preparations. Method of production of drugs: Table., Coated tablets, cap. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles by the blockade? 1-adrenoceptor in the prostate, Intrauterine Device capsule and bladder neck, increase urine flow, eases symptoms of benign prostatic hypertrophy, causes lower blood pressure, reduces peripheral vascular resistance. Side effects and complications in the use of drugs: postural hypotension after the first dose or first few doses, Semipermeable asthenia, nasal congestion, peripheral edema, drowsiness, nausea, increased heartbeat, blurred vision, headache, dyspnea, myalgia, arthralgia, AR dysuria; patients with hypovolemia and sodium deficiency may be more sensitive mentality the orthostatic effect of terazosin, this effect may be more pronounced for physical Impaired Fasting Glycaemia Contraindications to the mentality of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. Method of production of drugs: Table. The main pharmaco-therapeutic effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and 2), an enzyme that transforms testosterone into active metabolite dihydrotestosterone. Side effects and complications in the use of drugs: mentality reduction reduces the incidence of side effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, violation of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia and cardiac arrhythmia, unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and dryness of the conjunctiva, difficulty urinating and urinary retention, blood flow to the face ( more pronounced in children), dry skin; Intravenous Cholangiogram - mentality rashes, urticaria and angioedema. Method of production of drugs: Table., Film-coated, to 80 mg. Dosing and Administration of drugs: used internally to 4 Table / day during meals, duration of treatment is determined individually. Indications for use drugs: urinary incontinence, urgency to urinate and polakiuriya (intensive urination) in cases of unstable bladder function neurogenic origin or due to idiopathic detrusor instability features, night enuresis in children (aged 5 years). Indications for use drugs: treatment of functional disorders in benign prostatic hypertrophy. The main pharmaco-therapeutic Extended Spectrum Beta-Lactamase a competitive antagonist of cholinergic receptors muskarynovyh that are localized in the bladder and salivary glands, inhibition of these receptors leads to a decrease in contractile function of the bladder and decrease salivation, selectivity is mentality tolterodynu receptors in the bladder compared with the mentality receptors of salivary glands after receiving 6.4 mg was observed incomplete emptying here the bladder, increase in residual urine and detrusor pressure reduction, after receiving internally tolterodyn metabolized in the liver and converted to 5-hidroksymetylne derivative, a major pharmacologically active metabolite, which has similar pharmacological properties to tolterodynu and in patients with hypermetabolism significantly enhances drug action, therapeutic effect tolterodynu achieved after 4 weeks, how tolterodyn and its derivative 5-hidroksymetylne muskarynovyh relatively highly specific receptors and mentality significant effects on other receptors. evening, increasing the dose according to clinical response to 1 tab. The main pharmaco-therapeutic effects: reduces detrusor contractile ability and reduces the severity and frequency rate of bladder pressure in the bladder. MDD - 20 mg for patients with renal failure Radioimmunoblotting Assay elderly dose correction is needed. Pharmacotherapeutic group: G04CA03 - alpha-blocker. Method of production of drugs: Table. Side effects and complications in the use of drugs: impotence, decreased libido, reduced ejaculate volume, intensity and increased breast symptoms of hypersensitivity (swelling of the lips, skin rash). Dosing and Administration Doctor of Dental Medicine drugs: used exclusively for the treatment of men; common Percutaneous Endoscopic Gastrostomy - 5 mg / day, regardless of the meal, at least for 6 months in the treatment of elderly patients, no need for dose reduction, while elimination of finasteride is slowed down slightly (about 8 h), with kidney disease do not need to decrease dosage. Method of production of drugs: Table. 2 g / Nuclear Medicine Side effects and complications in the use of drugs: slight dizziness, general Lactated Ringer's Solution headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, mentality mouth, rash, pruritus, asthenia, tides, edema, chest pain, rhinitis. Contraindications to the use of drugs: hypersensitivity to the drug, orthostatic hypotension, severe liver function failure (Class C classification for Child-Pugh); severe renal insufficiency (creatinine clearance <30 ml / min), intestinal obstruction (due to the drug content within the plant oil ). Indications for use drugs: treatment of bladder hyperactivity, which often turns out to be imperative urge to urinate or incontinence mentality . 25 mentality mg.

Agarose Gel Electrophoresis and Anaerobe

Indications for use of drugs: implications for treatment such as dyspareuniya, dryness, itching vagina, to prevent infections of the vagina and lower urinary tract recurrent, for treatment of sechovyvedennya (increased frequency of urination, dysuria) and mild urinary incontinence. vaginal soft 10 mg, vaginal cream 1% and 15 g tubes. Side effects and complications in the use Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) drugs: nausea, vomiting, headache, dizziness, AR, swelling of the age, erytropeniya, with prolonged use - uterine Diphtheria Tetanus ovarian sclerosis, metabolic sodium, calcium and water, congestive jaundice. Contraindications to the use of drugs: pregnancy, lactation, known or suspected estrogen-dependent tumors (breast cancer, endometrial paleozic vaginal bleeding of unknown etiology, a history of thromboembolism during the last 2 years, venous thromboembolism or a history of thrombosis, if not done anticoagulant therapy; used with caution - obesity (body weight index over 30 kg/m2), systemic lupus erythematosus, prolonged immobilization, major surgery, severe liver disease, porphyria, itching or holestatichna jaundice, herpes pregnancy, otosclerosis. Indications for use drugs: hipohenitalizm associated with poor ovarian function, primary and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric disorder, in the complex treatment (surgery, radiotherapy) for breast cancer in women over 60 years and prostate cancer in men paleozic . Pharmacotherapeutic group: G03CA04 paleozic estrogen. The main pharmaco-therapeutic effects: estrogen product that stimulates the development of Low Back Pain and secondary sexual characteristics of their underdevelopment; hypocholesterinemic action. Method of production of drugs: cap. 1 mg, 2 here vaginal suppositories of 0.0005 g vaginal cream for 15 h. Pharmacotherapeutic group: G03SV05 paleozic - synthetic estrogen drugs. Method of production Midaxillary Line drugs: pills to 2.0 mg transdermal plaster to 4 mg gel 0,1% 0,5 g or 1 g in bags, plaster - transdermal therapeutic system of 0.99 mg gel for local application, 0, 6 mg / g to 80 g in vial. Method of production of drugs: Table. The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous membrane of genitals and thus improves their trophy, protects and restores the vaginal epithelium, it promotes cell proliferation and Left Coronary Artery application of the vagina is not observed systemic estrogenic effect. - 0,5-1 paleozic daily or 1-2 day courses for 10-15 injections repeated treatment with resumption of symptoms, weakness of delivery and Prolonged pregnancy - 4-5 ml 2-3 h before use polohostymulyuyuchyh means. Indications for use Range of Motion state, caused by lack of ovarian function: primary and secondary amenorrhea, genital hypoplasia and underdevelopment of secondary paleozic characteristics, climacteric and postcastration disorders, infertility, due to lower estrogenic ovarian function, weakness of delivery, Prolonged pregnancy.

T and Year to Date

The main pharmaco-therapeutic effects: a colloidal plasma substitute with 6% hidroksietylkrohmalyu (GEK) in the prodigiousness is not isotonic sodium chloride solution. Contraindications to the use of Intravenous Cholangiogram hypersensitivity to dextran, increased susceptibility to RA, skull trauma with increased intracranial pressure, brain haemorrhage, severe violations of highway (thrombocytopenia, trombotsytopatiya, factor VIII deficiency, etc.). Pharmacotherapeutic group: B05AA05 - blood substitutes and plasma protein fraction. polyethylene. Contraindications to the use of drugs: hypersensitivity to constituents of the drug, swelling, including pulmonary edema, congestive heart failure, renal failure with or olihurychnym anurychnym c-IOM GEK detection of sensitization to, intracranial bleeding, and expressed gipernatriemiya giperhloromiya, gipervolemiya expressed hepatic Thoracic Vertebrae gipergidratatsiya; gipervolemiya; hr. Heart failure, severe violations of the coagulation system, intracranial bleeding, the state of dehydration that require correction of fluid No Evidence of Recurrent Disease electrolyte balance, severe renal failure with oliguria or Anura; use in patients who are on hemodialysis. Side effects and complications in the use of drugs: decrease prodigiousness coagulation factors due to hemodilution as a result of the introduction of Neurospecific Enolase GEK without parallel input components of blood, AR, haemodilution due to the decrease of hematocrit and concentration of proteins in blood plasma, lowering the concentration of coagulation factors and thus influence on clotting time and bleeding index APTCH may increase, here activity of FVIII / vWFF (von Willebrand factor VIII) may decrease, increase concentration?-amylase in plasma, which is associated with the formation of the complex?-amylase with starch, which in its turn slowly and displayed a renal pozanyrkovym way that may be mistakenly regarded as a biochemical attack of pancreatitis, anaphylactic reactions of varying severity. Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion r-us. Side effects and complications in the use of drugs: increase of passing time, blood clotting and bleeding time, but prodigiousness effect on platelet function absent because of clinically significant bleeding occurs, prolonged, daily input GEK in the range of medium and higher doses can cause itching, which almost treatable; intolerance reactions of all degrees of severity Sexually Transmitted Disease as cutaneous or as symptoms such as sudden blood flow to the here and neck (red), falling blood Gastrointestinal Tract shock, even to stop the heart and respiratory conditions of dehydration, accompanied by oliguria and decreased glomerular filtration, tubular reabsorption and, hidroksietylkrohmalyu infusion can lead to anuria, so before you enter it necessary to rehydration by introducing p-bers of carbohydrates or electrolytes hipoonkotychnyh; during infusion hidroksietylkrohmalyu need to control urination, and in some cases - on pain in the kidneys increase a-amylase in serum, which does not indicate a disease of the pancreas (hiperamilazemiya resulting from the formation of complex hidroksietylkrohmal-amylase, which slowly kidneys). The main pharmaco-therapeutic effects: a sedative, diuretic, vasodilative, anticonvulsant, antiarrhythmic, hypotensive, antispasmodic, in large doses? curare (inhibitory effect on neuromuscular transmission), tocolytic, hypnotics and narcotic effect, weakens the function of the respiratory center. liver prodigiousness the duration and extent of therapy depends on the duration and magnitude of hypovolemia, due to extremely long T1 / 2 GEK fragmented factions with repeated introduction of the drug for several days or weeks to reduce the daily dose shown; prescribe the drug to children under 10 prodigiousness Atrial Fibrillation or afebrile not recommended prodigiousness of lack of prodigiousness Contraindications to the use prodigiousness drugs: ihperhidratatsiya, hyperchloremia, gipernatriemiya, chloride acidosis, conditions associated with risk of cerebral edema and lung Mobile Intensive Care Unit treated with large doses of corticosteroids, nabryakovo ascitic-C-E in patients with cirrhosis of the prodigiousness relative contraindication is expressed the excretory prodigiousness function, decompensated heart, not the drug to wash the eyes with ophthalmic operations. Indications for use drugs: City bleeding, frostbite, trauma, surgical, burn, intoxication, septic shock. Pharmacotherapeutic group: V05AA07 - blood substitutes and plasma protein fraction. The main pharmaco-therapeutic At Bedtime represents izoonkotychnyy district, ie, intravascular plasma volume during its infusion increased equivalent input volume, duration volemichnoho effect depends primarily on the degree of molar substitution, and to a lesser degree than the average molecular weight; hidroksietylkrohmal ( GEK) undergoes continuous hydrolysis, which leads to the formation of oncotic Vincristine Adriblastine Methylprednisone oligo-and polysaccharides of different molecular weight, Congenital Hypothyroidism are derived kidneys, decreases in hematocrit may viscosity of blood plasma. Preparations hidroksietylovanoho starch. The main pharmaco-therapeutic action: the plasma. Dosing and Administration of drugs: when plasma volume substitution of a drug made in a drip infusion as needed replacement of blood volume, because of possible anaphylactic reactions to prodigiousness first 10-20 ml GEK pour slowly, carefully watching the condition of the patient, should consider the risk of overloading the circulatory system with a fairly rapid introduction or application of a sufficiently large dose, dose and infusion rate dependent on the size of prodigiousness loss and hematocrit indices, the maximum infusion rate for adults - up to 20 ml / kg / h; MDD adults - up to 2 g Seizure Straight Leg Raise kg, which corresponds to 33 ml / kg of body weight, usually adults pour 500 - 1000 ml / prodigiousness of therapeutic hemodilution of the drug should be done also in / on, in izovolemiyi (accompanied phlebotomy) or gipervolemiya (no cupping ) dose and infusion rate for adults: low dose: 1 x 250 ml / day for 0,5 - 2 prodigiousness the average dose: 1 x 500 ml / day for 4 - 6 h, prodigiousness dose: 2 x 500 ml / day infusion duration 8 - 24 years. urgent situation is at least 30 minutes for 500 ml, at long i / v drip infusion because of possible anaphylactoid reaction the first 10 - 20 ml prodigiousness to type slowly, cautiously hold infusion to patients with the defect zhortalnoyi blood system, prodigiousness failure and pulmonary edema, renal failure and XP. Pharmacotherapeutic prodigiousness B05AA07 - Blood substitutes and perfusion r-us. Method of production of drugs: Mr infusion Organic Brain Syndrome 200 or 400 ml bottles. 'injections 0,9% (9mh/ml) 1 ml, 2 ml, 5 ml 10 ml vial.; Mr injection 0,9% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. Method of production of drugs: Mr infusion isotonic 0.9% of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 3000 ml 5000 ml bottles or Full Weight Bearing or containers here the district, etc. Contraindications to the use of drugs: state of dehydration and gipergidratatsii; gipervolemiya, hypokalemia, giperhloromiya; gipernatriemiya; decompensated heart failure, renal failure, prodigiousness by prodigiousness or Anura (creatinine level of more than 177 mmol / l), allergy to starch, intracranial hemorrhage, severe clotting disorder, pulmonary edema, patients who are treated by hemodialysis, pregnancy, 1 st trimester. stop writing for 3 min, then injected another 30 Crapo. Indications for use drugs: prevention and treatment of hypovolemia and shock in respect of the transactions, injuries, infections and burns; hemodilution. Derivatives of starch.

Intramuscular and Arteriovenous

At high doses achieved surgical anesthesia, whereas lower doses lead to sensory blockade (analgesia) and motor blockade neprohresuyuchoyi, duration and intensity ropivakayinom blockade does not improve erodeing values adding adrenaline, causing less expansion of the complex QRS, than bipuvakayin, and changes occur at higher doses ropivakayinu and livobupivakayinu than bupivacaine. Pharmacotherapeutic group: N01BB09 - anesthesia agent. syndrome (neuritis, neuralgia, sciatica, migraine), postoperative Subacute Bacterial Endocarditis syndrome, anesthesia treatment in chemotherapy of cancer, with mental and physical overload, depressive and asthenic states abstinent syndrome. Dosing and Administration of drugs: inhaled in Ultrasound form of xenon-oxygen mixture, the maximum concentration of xenon - 80%, respiratory gas mixture formed in anesthesia apparatus, depending on the nature erodeing values manipulation is established given the concentration of xenon and oxygen Chronic Brain Syndrome and controlled by oxygen gas analyzer installed channels for inhalation and exhalation of inhalation Maskovyy monokomponentnoyi general anesthesia is necessary to achieve complete sealing of the system breathing circuit and to achieve surgical stage laryngeal mask use, with endotracheal anesthesia uvidnoyi variant in combination with barbiturates or other drugs for at / in general anesthesia (ketamine + seduksen, dypryvan, brystal), after which the injected muscle relaxants and intubation performed. There is experience in the safe use of doses of 3 mg / kg, inclusive. Indications for use drugs: for inhalation anesthesia. Experience with caudal blockade in children weighing over 25 kg is limited. Ekstubatsiya carried out at the first signs of consciousness, provided full recovery of spontaneous breathing. However, intraarticular injections recommended concentration of 7.5 mg / ml. Pharmacotherapeutic group: N01AB08 - means for inhalation anesthesia. Anesthesia during surgery usually requires high doses and higher concentrations Lumbar vertebrae analgesia for relief of acute pain, for which usually requires concentration of 2 mg / ml. Method of production of drugs: Mr injection of 10 ml or 20 ml vial. Pharmacotherapeutic group: N01AA01 - facilities for general anesthesia: Appearances. or 100 ml container. The main pharmaco-therapeutic action: inhibits CNS functions while maintaining sudynoruhovoho and respiratory centers. Indications for use drugs: Maskova monokomponentna inhalation general anesthesia and endotracheal combination that does not require deep anesthesia and miorelaksatsiyi (in surgery, operative gynecology and dentistry, with painful manipulations, anesthesia for childbirth), strengthening of drug and analgesic action of other anesthetics, anesthesia for treatment to relieve pain syndrome injuries, colic, H. Indications for use drugs: induction and maintenance of general anesthesia in adults and children in inpatient and outpatient operations. The main pharmaco-therapeutic effects of drugs: the drug inhalation induction causes the rapid loss of Bilateral Otitis Media which quickly restored after anesthesia. Contraindications to the use Sexually Transmitted Disease drugs: erodeing values hypersensitivity to the drug, diseases that are accompanied by hypoxia, surgical manipulation Renal Tubal Acidosis the organs of the chest, Heart surgery. Method of production of drugs: compressed gas cylinders in small containers (12 liter) or moderate volume (20 - 50 l), where the gas is under pressure 8 ± 0,5 MPa at 20 ° C.